Contribution of flavin-containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 6, 1999, Pages 567-571

  Narimatsu, Shizuo ^a   Yamamoto, Shigeo ^a   Kato, Rika ^b   Masubuchi, Yasuhiro ^b   Horie, Toshiharu ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cytochrome P450; Enzyme kinetics; Flavin containing monooxygenase; Methimazole; Rat liver microsome; SKF 525 A

Indexed keywords

CYTOCHROME P450; DESIPRAMINE; IMIPRAMINE; PROADIFEN; QUERCETIN; THIAMAZOLE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; DEMETHYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; OXYGENATION; PH;

EID: 0033047598     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.567     Document Type: Article

References (20)

1. Sallee F. R., Pollock B. G., Clin. Pharmacokinet., 18, 346-364 (1990).
2. Von Bahr C., Birgersson C., Morgan E. T., Erikson O., Goransson M., Spina E., Woodhouse K., Xenobiotica, 16, 391-400 (1986).
3. Lemoine A., Gautier J. C., Azoulay D., Kiffel L., Belloc C., Guengerich F. P., Maurel P., Beaune P., Leroux J. P., Mol. Pharmacol., 43, 827-832 (1993).
4. Ohmori S., Takeda S., Rikihisa T., Kikuchi M., Kanakubo Y., Kitada M., Biol. Pharm. Bull., 16, 571-575 (1993).
5. Baldessarini R. J., "Goodman and Gilman's The Pharmacological Basis of Therapeutics," 7th ed., ed. by Goodman Gilman A., Goodman L. S., Rall T. W., Murad F., Macmillan Pub. Co., New York, 1985, pp. 413-422.
6. Gram L. F., Bjerre M., Kragh-Sorensen P., Kvinesdal B., Molin J., Pedersen O. L., Resbz N., Clin. Pharmacol. Ther., 33, 335-343 (1983).
7. Brosen K., Otton S. V., Gram L. F. Clin. Pharmacol. Ther., 40, 543-549 (1986).
8. Koyama E., Chiba K., Tani M., Ishizaki T., J. Pharmacol. Exp. Ther., 281, 1199-1210 (1997).
9. Rapp W., Noren M. B., Pedersen F., Acta Psychiat. Scand., 49, 77-90 (1973).
10. Dencker S. J., Bake B., Acta Psychiat. Scand., 54, 74-78 (1976).
11. Lemoine A., Williams D. E., Cresteil T., Leroux J.-P., Mol. Pharmacol., 40, 211-217 (1991).
12. Ziegler D. M., Drug Metab. Rev., 19, 1-32 (1988).
13. Omura T., Sato R., J. Biol. Chem., 239, 2370-2378 (1964).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
16. Narimatsu S., Yamamoto S., Koitabashi T., Kato R., Masubuchi Y., Suzuki T., Horie T., Biol. Pharm. Bull., 22, 253-265 (1999).
17. Murray M., Reidy G., Pharmacol. Rev., 42, 85-101 (1990).
18. Guo Z., Raeissi S., White R. B., Stevens J. C., Drug Metab. Dispos., 25, 390-393 (1997).
19. Masubuchi Y., Takahashi C., Fujii N., Horie T., Suzuki T., Imaoka S., Funae Y., Narimatsu S., Drug Metab. Dispos., 23, 999-1003 (1995).
20. Masubuchi Y., Igarashi S., Suzuki T., Horie T., Narimatsu S., J. Pharmacol. Exp. Ther., 279, 724-731 (1996).